Why do we get together like this? Day 1 of the Innovation Network Gathering was a powerful reminder that real change happens when we collaborate and listen. Check out the highlights of Day 1 of The Gathering 2024. #ING2024 #community #ideas #impact
Innovation Network Gathering
Health and Human Services
We Gather to anticipate and shape the future of human-centered clinical trial services and technologies.
About us
Gather people in order to anticipate and shape the future of human-centered clinical trial services and technologies We are all more aware of the need for human-centric clinical research. Call it patient-centric or participant-centric – the human is at the center. The sector is changing, and we need digitally competent trials to keep up with that change. We can bring people together and amplify thought leaders to anticipate and shape the future of human centered clinical research services and technology.
- Website
-
https://innovationgathering.network/
External link for Innovation Network Gathering
- Industry
- Health and Human Services
- Company size
- 2-10 employees
- Type
- Privately Held
Employees at Innovation Network Gathering
Updates
-
Thanks ACRO for your work on RBQM!
Author Spotlight - Part 1! ACRO's RBQM Working Group has released it latest paper, "Risk-Based Quality Management: A Case for Centralized Monitoring," diving into the value of centralized monitoring and a real-life example of how it can be implemented. Check out highlights below and read the full paper: https://lnkd.in/e8ms3WQr
-
-
🛑 🤝🦻
Stop, Collaborate, and Listen. 👊 Why do great ideas fail? Having launched new products myself (six out of seven worked—early failure teaches the most!) and now reviewing 2,000 startups a year at HealthX Ventures, I have some thoughts on this, which I shared with the Innovation Network Gathering. While the examples in this particular talk are about clinical research efficiencies, the principles apply everywhere. Watch here: https://lnkd.in/ghpvBkWG Key takeaways (spoiler alert): 1. Understanding the PROBLEM is critical. You cannot overlook this or oversimplify it. What problem are you actually focused on solving and for whom? What are the intricacies of it? One company with $16B in revenue even got this wrong, which led to its demise. 2. De-risk ideas by listening to many more people than you’d think. Don’t fall into the trap that YOU know it all. Myopia and oversimplification leave too many companies with potential to miss building a full solution that actually solves the problem. You or your internal SMEs can’t answer it all. Get real input from buyers, influencers, and importantly USERS who are not the buyers. Then you will be sufficiently informed and can decide what to do about the input. 3. There is risk in taking no risk. This applies to customers, to start-ups, and investors. Calculated risks (with knowledge of points 1 and 2) can actually help you avoid failure and drive faster success. Shout out to Jeff Smith and Michelle D. Jones for putting on such a high quality, engaging, inspiring event and for thoughtful support that leaves anyone for the better. Shout out to Bo Lora from AWS who has equal passion about defining the problem. Thank you Brad Hightower for being the brave soul that shares the hard truth for the good of clinical research, and Bill Illis at Novartis and TransCelerate BioPharma Inc. for laying the groundwork for integration standards that have promise to enable smoother collaboration across clinical research sites and sponsors. As we continue navigating the complexities of innovation—be it in clinical research or any other field—let’s remember that success is built on a clear understanding of the problem, a willingness to learn from diverse perspectives, and a commitment to true collaboration.
-
Innovation Network Gathering reposted this
Stop, Collaborate, and Listen. 👊 Why do great ideas fail? Having launched new products myself (six out of seven worked—early failure teaches the most!) and now reviewing 2,000 startups a year at HealthX Ventures, I have some thoughts on this, which I shared with the Innovation Network Gathering. While the examples in this particular talk are about clinical research efficiencies, the principles apply everywhere. Watch here: https://lnkd.in/ghpvBkWG Key takeaways (spoiler alert): 1. Understanding the PROBLEM is critical. You cannot overlook this or oversimplify it. What problem are you actually focused on solving and for whom? What are the intricacies of it? One company with $16B in revenue even got this wrong, which led to its demise. 2. De-risk ideas by listening to many more people than you’d think. Don’t fall into the trap that YOU know it all. Myopia and oversimplification leave too many companies with potential to miss building a full solution that actually solves the problem. You or your internal SMEs can’t answer it all. Get real input from buyers, influencers, and importantly USERS who are not the buyers. Then you will be sufficiently informed and can decide what to do about the input. 3. There is risk in taking no risk. This applies to customers, to start-ups, and investors. Calculated risks (with knowledge of points 1 and 2) can actually help you avoid failure and drive faster success. Shout out to Jeff Smith and Michelle D. Jones for putting on such a high quality, engaging, inspiring event and for thoughtful support that leaves anyone for the better. Shout out to Bo Lora from AWS who has equal passion about defining the problem. Thank you Brad Hightower for being the brave soul that shares the hard truth for the good of clinical research, and Bill Illis at Novartis and TransCelerate BioPharma Inc. for laying the groundwork for integration standards that have promise to enable smoother collaboration across clinical research sites and sponsors. As we continue navigating the complexities of innovation—be it in clinical research or any other field—let’s remember that success is built on a clear understanding of the problem, a willingness to learn from diverse perspectives, and a commitment to true collaboration.
Why Great Ideas Fail — Innovation Network Gathering
innovationgathering.network
-
Innovation Network Gathering reposted this
In this week's issue, we'll review Agendia’s diverse, high-enrolling trial and how sponsor companies of investigational trials might benefit from its experiences, how AI could help us decipher the "language of biology" and streamline drug discovery, what stood out to clinical trial experts in 2024, how the clinical trial landscape for small cell lung cancer is evolving, and other popular insights! William Audeh, Agendia | Innovation Network Gathering, Tala Fakhouri | Dan Schell | Novotech | Chintan Desai, Stryde Research | Helen Marks, Medical Research Network | Robert Barrow, MindMed | Ben Baumann, OpenClinica | Daniel Fox, MPH, PhD | Parexel
Learnings From A Highly Diverse Observational Study Of 17,000+ Patients, Clinical Trial Surprises in 2024, and More
Clinical Leader on LinkedIn
-
🐋 Artyc is Official Selection participant at The Whale Tank 2024. Watch the full pitch on our website! https://lnkd.in/gcQ777Y2
The 5th edition of Cool Currents is out – huge thank you to Drew Telford for putting together another great issue. This time, we covered Hannah Sieber’s awesome pitch at the Innovation Network Gathering. We also shared key takeaways from three healthcare conferences, and an in-depth analysis related to carbon reduction. To catch the full issue, check out the comments below.
-
-
The work around USDM is a big deal. Heed Bill Illis. He spits truth.
Twice as nice! Our second webinar in the Digital Data Flow (DDF) Solution Showcase series – hosted with CDISC on December 5 – will provide participants the opportunity to hear the latest news and presentations from a range of solution providers intent on improving the all-important flow of data in clinical research. Panelists: Poorya Amini, Founder and CEO, Risklick Katja Glass, Open-Source Ambassador, Consultant, Novo Nordisk Nicolas De Saint Jorre, Lead Product Architect, Novo Nordisk Learn more and register: https://lnkd.in/eZpHe-jN
-
-
How to Unlock Innovation Within Large Pharma | Julius Kusserow What is causing this friction between data managers and technology? 🔗 Watch the full talk on our website https://lnkd.in/gNikueT9 Julius delves into the complexities of driving innovation within pharmaceutical organizations. Through real-world examples, Julius highlights how misalignment between processes and tools leads to inefficiency and frustration. By emphasizing the importance of cross-functional leadership and prioritizing process over technology, he demonstrates how these changes can lead to better results, streamlined workflows, and ultimately, happier teams. About Julius Kusserow Julius is an R&D Data Standards expert at Bayer, where he leads a team focused on managing clinical standards and automation within the company. With over 20 years of experience in the pharmaceutical industry, Julius brings a unique blend of expertise from both the pharma and CRO sectors. His background spans various roles in data management, statistics, statistical programming, standards management, and quality management—giving him a comprehensive view of clinical development processes and a deep understanding of how to drive innovation through standardization and automation. #ING2024 #clinicaltrials #innovation
-
-
🏆 The three award winners from this year's Whale Tank have demonstrated remarkable innovation and vision in tackling key challenges in biopharma: 🐋 OmniScience – Revolutionizing clinical trials management and operations 🔍 TrialHub – Global Standard of Care Insights in a Click 🎮 BENTO BIOLOGY PLATFORMS – Transforming clinical trial participation into an immersive user experience Thank you Angela Holmes, MSBME, Maya Zlatanova, Kelly M. McVearry for your inspiring efforts and for making waves in clinical trials. 🎥 Watch all showcase videos to learn more about these innovative solutions: https://lnkd.in/gdcx6RX8 #ING2024 #WhaleTank #Innovation #ClinicalTrials
-
Innovation Network Gathering reposted this
Sure, #AI offers a lot of opportunity for drug development and clinical research, but in this short video from the Innovation Network Gathering, Tala Fakhouri of the #FDA also addresses the myths and challenges that regulatory bodies like the FDA must navigate. https://lnkd.in/gfAp64pC
-